Image | USDAgov
2015 is proving to be a banner year for mobile innovation in the field of Health, with new apps appearing daily for the purpose of making the lives of patients and their family members easier. We have seen applications of all kinds, like those which help to control apnoea, manage springtime allergies and even help surgeons to learn to operate. Now we present an app that can make the day-to-day lives of those suffering from anaphylaxis a lot more bearable.
Anapphylaxis is a mobile application whose objective is to perfectly conserve the substance that anaphylaxis patients must self-administer via injection in the event of an emergency. Anaphylaxis is a serious and immediate allergic reaction triggered by organic substances, like food or medicines. These reactions require very fast responses involving the administration of epinephrine to prevent fatal consequences, so doctors normally prescribe their patients an epinephrine auto-injector to give themselves the shot if necessary. The problem lies in the maintenance of the medicine, as high temperatures and excessive light quickly damage the substance, and can even render its use counterproductive.
The Anapphylaxis app was created with a view to supervising and keeping the auto-injectable epinephrine in perfect condition. The product features smart packaging to store the medicine, connected via Bluetooth to the app, enabling users to monitor the condition of their epinephrine at all times.
The application ensures that the medicine is maintained in good condition, tracks the auto-injector’s expiration date, warns users if they forget it at home, and includes instructions to inject it properly. It also warns relatives and medical services in the event of an emergency, so as to ensure proper patient care. The app can even be very useful for the parents of children and adolescents who suffer from anaphylaxis, as it can inform them of any problems with the auto-injector and report on the location of any anaphylactic episodes.
The team that oversaw the development of this mobile application is made up of Spanish professionals working in fields as wide-ranging as Medicine, Business Development, Patents, Engineering, and Information Technologies. Anna Sala, Adrián Curran, Joaquim Trias, Xavier Verdaguer, Francesc Trias and Xavier Guillem also participated in the project.
Anapphylaxis is an example of a success story arising from a project presented at Imagine Silicon Valley, the programme organised by the Imagine Creativity Center to generate ideas that change the world. As a result, on 12 June it was upheld as an example of achievement from a previous edition at the presentation of the programme’s 5th edition in Barcelona, which this year features 12 participating projects, called “Dreamers.” The programme will wind up on 29 July in San Francisco with a public presentation of its ideas.